TDOC stock: buy or sell?

TDOC stock price: $95.60 -1.35% At close on January 17th, 2020

Updated on:
January 17th, 2020


After marking all time highs on Monday, Teladoc Health depreciated -1.35% to $95.60. On Monday TDOC boosted an extraordinary 11.26%.

Teladoc, Inc. operates a telehealth platform that provides on-demand healthcare services to its members in the United States.

Should I buy TDOC stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at we prefer those that are simple but successful.

Currently, 2 buy setups match with Teladoc Health stock now:

Buy setupElegible
New all-time highYes
New 52 week highYes
Price crossing up 200d MANo
100d MA crossing up 200d MANo

Is Teladoc Health stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. At, we gathered 6 ratings published for TDOC stock in the last month.

The general sentiment of these ratings is bullish for TDOC stock, with 4 positive ratings.
Is TDOC a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-19JPMorgan Chase & Co.n/aOverweight
2019-9-12Deutsche Bankn/aBuy
2019-8-6SunTrust BanksBuyPositive
2019-7-2Jefferies Financial Groupn/aBuy
2019-6-13Bank of American/aBuy
2019-3-4SunTrust BanksBuyPositive

TDOC stock analysis

Daily outlook

After topping to all time highs on Monday, Teladoc Health depreciated -1.35% today to $95.60.

On Monday, TDOC hit a new all time high, pushing higher than tops. Check different trading setups that use ATHs as triggers. After topping to all time highs on Monday, Teladoc Health depreciated -1.35% today to $95.60. From a daily perspective, TDOC is in a short term uptrend after plotting its last bottom ($84.78, on Jan 10th) higher than the previous bottom, and its last top ($98.97, on Monday) also over the previous top. Now trading in between its last bottom and last top TDOC might consolidate in a plain range, waiting to break out over $98.97 or down under $84.78. Since price and SMA200d lines crossed up on September, TDOC climbed $36.44 (61.60%).

TDOC stock chart (daily)

Weekly outlook

Teladoc Health ended this week at $95.60 after topping to a new all time high ($98.97) and climbed an extraordinary 12.26%.

Teladoc Health stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Early September TDOC price bounced up over the SMA of 40 weeks that acted as support stopping new slides. Since SMA20d and SMA40w crossed up early July, TDOC price climbed $29.19 per share (43.95%).

TDOC stock chart (weekly)

TDOC stock price history

TDOC stock went public on July 1st, 2015 with a price of $29.901. Since then, TDOC stock surged a 219.70%, with a yearly average of 54.90%. If you had invested $1,000 in TDOC stock in 2015, it would worth $2,197.00 today.

1: Adjusted price after possible price splits or reverse-splits.

TDOC stock historical price chart

TDOC stock reached all-time highs on Monday with a price of $98.97.

TDOC stock price target is $81.80

Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. We have 5 price predictions for Teladoc Health stock posted in the last 30 days:
TDOC stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-9-19JPMorgan Chase & Co.Reiterates$82.00$83.001.2%
2019-9-12Deutsche BankInitiatesn/a$76.00-
2019-8-6SunTrust BanksRaises Targetn/a$80.00-
2019-7-2Jefferies Financial GroupSet Price Targetn/a$95.00-
2019-3-4SunTrust BanksRaises Targetn/a$75.00-
(in average)$82.00$81.800.0%
Moving in a range from $95.00 and $75.00, the price prediction for Teladoc Health stock is $81.80. In average, analysts' outlook on TDOC price target is stable from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

On February, Teladoc Health was in line with the estimates of the experts and posted an EPS of $-0.35 per share. Unfortunately, reported EPS is not yet available in our database.
TDOC earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual revenues report draw an astounding growth of 79.14% to $417.91 M dollars. Aligned with this, its profit margin (compared to sales) climbed to -23.23%, that is $-97.08 million.

TDOC annual Sales and Income evolution
2013$20 M-$-6.02 M-30.2%-
2014$44 M118.62%$-17.04 M-39.1%183.01%
2015$77 M77.78%$-58.02 M-75.0%240.55%
2016$123 M59.15%$-74.22 M-60.3%27.91%
2017$233 M89.42%$-106.78 M-45.8%43.88%
2018$418 M79.14%$-97.08 M-23.2%-9.08%

Quarterly financial results

Teladoc Health reported $122.74 million in sales for 2018-Q4, a 10.62% up compared to previous quarter. Reported quarter earnings marked $-24.88 million with a profit margin of -20.27%. Profit margin remained constant a 0.70% compared to previous quarter when profit margin was -20.97%. When comparing turnover to same quarter last year, Teladoc Health sales marked a super good gain and rocketed a 59.11%. Looking back to recent quarterly results, Teladoc Health posted 6 positive quarters in a row.
TDOC quarterly Sales and Income evolution
2017-Q2$45 M-$-15.42 M-34.6%-
2017-Q3$69 M53.96%$-31.33 M-45.6%103.18%
2017-Q4$77 M12.37%$-44.38 M-57.5%41.66%
2018-Q1$90 M16.21%$-23.86 M-26.6%-46.24%
2018-Q2$95 M5.48%$-25.08 M-26.5%5.10%
2018-Q3$111 M17.35%$-23.26 M-21.0%-7.24%
2018-Q4$123 M10.62%$-24.88 M-20.3%6.94%
2019-Q1$129 M4.75%$-30.15 M-23.4%21.19%

Teladoc Health ownership

When you are planning to buy a stock, it's worth to overview its ownership structure.

Teladoc Health shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 1.11% of all shares.

Bearish positions for TDOC stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related companies:

Market cap$6.9 B$1.4 B$371.2 M
Total shares72.4 M185.6 M117.8 M
Float shares71.5 M139.1 M101.8 M
  - Institutional holdings (%)128.7%96.0%96.1%
  - Insider holdings (%)1.1%1.5%6.2%
Shares in short selling0.0%0.0%0.0%

TDOC summary

Friday, January 17th, 2020
Day range$95.20 - $97.87
Previous close$96.91
Session gain-1.35%
Average true range$3.42
50d mov avg$82.66
100d mov avg$75.06
200d mov avg$68.32
Daily patternlt06a
Weekly pattern lt06a

Teladoc Health performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. In the following table, we compare Teladoc Health to Brookdale Senior Living and Community Health Systems:
TDOCTeladoc Health38.11%39.46%53.25%
BKDBrookdale Senior ...-15.47%-3.81%-8.50%
CYHCommunity Health ...-24.46%43.84%-22.22%

Teladoc Health competitors

Creating a list of competitors for Teladoc Health it's a hard job. We selected 2 public companies that are related to and can be considered as competitors of Teladoc Health: